Frequently Asked Questions about the Journal of Informed Pharmacotherapy
What is the JIP?
-
The JIP is a peer-reviewed online journal dedicated to the practice of rational pharmacotherapy through the use of evidence-based principles.
-
The JIP fosters the rapid widespread dissemination of original research findings, as well as information intended to help pharmacotherapy practitioners (i.e. pharmacists, physicians, nurses and other health care providers) cenforce 100 provide better care for their patients.
Why was the JIP created?
-
The idea for the Journal arose out of a recognized need for the following:
-
A new peer-reviewed journal that focuses on pharmacotherapy
-
A journal that provides pharmacotherapy literature reviews which highlight, condense, interpret and put this information into proper perspective using evidence-based principles.
-
An alternative to traditional hardcopy distribution to facilitate the rapid and worldwide dissemination of original research activity reports.
-
A journal that is accessible to all, for a price that all can afford
-
What is the history of the JIP?
-
The idea for the JIP was originated in late 1998 by the Founding Editors (top left of this page). Since then, the Founding Editors have been busy forming an editorial board and the processes by which the JIP will fulfill its mission.
Who is expected to read the JIP?
-
The JIP is intended for any health care professional with an interest in optimizing pharmacotherapy.
What makes the JIP unique?
-
JIP is the only peer-reviewed online journal devoted entirely to pharmacotherapy
-
JIP provides a strong evidence-based perspective through peer-reviewed research and reviews of the pharmacotherapy literature which put the research findings into their proper context
-
JIP provides a venue for clinicians to widely disseminate research findings (the second it is placed on the Web, it is accessible from any internet terminal on the planet).
-
JIP provides more rapid dissemination of information than traditional print journals (for example, we expect turnaround time for articles to be a few weeks, vs. a few months for old-style journals)
-
JIP does not require a paid subscription to access
Is the JIP linked to the Pharmaceutical Industry?
-
No. There is no financial relationship between the JIP and any pharmaceutical company.
-
As with other respected peer-reviewed journals, relationships between authors and such companies must be declared in writing at the time of submission and the details will be provided to the readership in conjunction with any resulting publications.
How is the JIP organized?
-
The day-to-day operations of the JIP are run by the Founding Editors on a voluntary basis.
-
Section Editors have been selected based upon their recognized clinical and research expertise in a specific area of pharmacotherapeutics (e.g.. cardiology, infectious diseases, toxicology, etc.)
-
Section Editors are drawn mainly from the United States and Canada.
-
Expert reviewers have been drawn from the global pool of pharmacotherapeutics practitioners and researchers.